Adherent-free generation of functional dendritic cells from purified blood monocytes in view of potential clinical use

Hematology and Cell Therapy

Volumn 40, Issue 1, 1998, Pages 17-26

  Bernard, J ^a   Ittelet, D ^a   Christoph, A ^a   Potron, G ^b   Adjizian, J C ^c   Kochman, S ^a   Lopez, M ^d  

^a INSTITUT JEAN GODINOT   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c Etablissement de Transfus Sanguine   (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

CD86; Culture system; Dendritic cells; Immunotherapy; Maturation

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL DIFFERENTIATION; CELL ISOLATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION; TUMOR REJECTION;

ANTIGENS, CD; ANTIGENS, CD86; CELL ADHESION; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; MEMBRANE GLYCOPROTEINS; MONOCYTES;

EID: 0031952362     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Andreesen R, Scheibenbogen C, Brugger W, et al. (1990) Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating monocytes: a new approach to cancer immunotherapy. Cancer Res 50: 7450-7456
2. Bartholeyns J, Lombard Y, Poindron P (1988) Immunotherapy of sarcoma by adoptive transfer of resident peritoneal macrophages proliferating in culture. Anticancer Res 8: 145-152
3. Bartholeyns J, Lopez M, Andreesen R (1991) Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results. Anticancer Res 11: 1201-1208
4. Bender A, Sapp M, Schuler G, et al. (1996) Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood J Immunol Methods 196: 121-135
5. Bix M, Locksley RM (1995) Natural T cells: Cells that co-express NKRP-1 and TCR. J Immunol 140: 1548-1553
6. Boon T, Cerottini JC, Van den Eynde B, et al. (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12: 337-365
7. Caux C, Vanbervliet B, Massacrier C, et al. (1996) In vitro regulation of development and function of dendritic cells. Hematol Cell Ther 38: 163
8. Chakraborty NG, Okino T, Stabach P, et al. (1991) Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice. In vitro 5: 609-614
9. Chang TW, Kung PC, Gingras SP, et al. (1981) Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? Proc Natl Acad Sci USA 78: 1805-1808
10. Dunn PA, Tyer HW (1981) Quantitation of neutrophil phagocytosis using fluorescent latex beads. Correlation of microscopy and flux cytometry. J Lab Clin Med 98: 374 -377
11. Eymard JC, Lopez M, Cattan A, et al. (1996) Phase I/II trial autologous activated macrophages in advanced colorectal cancer. Eur J Cancer 32: 1905-1911
12. Faradji A, Bohbot A, Schmitt M,et al. (1991) Phase I trial of IV infusion of ex-vivo activated blood derived macrophages in patients with non small cell lung cancer toxicity and immunomodulatory effects. Cancer Immunol Immunother 33: 319-326
13. Fidler IJ, Kleinerman ES (1984) Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J Clin Oncol 2:937-943
14. Freudenthal PS, Steinman RM (1990) The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87: 7698-7702
15. Geppert TD, Lipsky PE (1987) Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3. J Immunol 138: 1660-1666
16. Hsu FJ, Benike C, Fagnoni F, et al. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2: 52-58
17. + leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 59:208-218
18. Lopez M, Fechtenbaum J, David B, et al. (1992) Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J Immunother 11: 209-217
19. Lopez M, Martinache C, Canepa S, et al. (1993) Autologous lymphocytes prevent the death of monocytes in culture and promote as do GM-CSF, IL-3 and M-CSF, their differentiation into macrophages. J Immunol Methods 159: 29-38
20. Lopez M, Bony V, Martinache C, et al. (1996) Tumoricidal potential of human macrophages grown in vitro from blood monocytes. J Exp Ther Oncol 1: 143-154
21. Mayordomo JI, Zorina T, Storkus WJ, et al. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med 1: 1297-1301
22. Pfeiffer S, Gooding RP, Apperley JF, et al. (1997) Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors. Br J Haematol 98: 973-982
23. + peripheral blood monocytes. J Immunol 157: 3850-3859
24. Reid CDL (1997) The dendritic cell lineage in haemopoiesis. Br J Haematol 96: 217-223
25. Reis e Sousa C, Stahl PD, Austyn JM (1993) Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178: 509-519
26. Romani N, Koide S, Crowley M, et al. (1989) Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented by immature epidermal Langerhans cells. J Exp Med 169: 1169-1178
27. Romani N, Gruner S, Brang D, et al. (1994) Proliferating dendritic cell progenitors in human blood. J Exp Med 180: 83-93
28. Romani R, Reider D, Heuer M, et al. (1996) Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196: 137-151
29. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J Exp Med 179: 1109-1118
30. Sallusto F, Cella M, Danieli C, et al. (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389-400
31. Shurin MR (1996) Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 43: 158-164
32. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Anna Rev Immunol 9: 271-296
33. + human blood dendritic cells for active immunotherapy. Exp Hematol 25: 227-232
34. Toujas L, Delcros JG, Diez E, et al. (1997) Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides. Immunology 91: 635-642
35. Van Wause JP, De Mey JR, Gossens JG (1980) OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J Immunol 124: 2708-2713
36. Zagury JF, Bernard J, Achour A, et al. (1993) Identification of CD4 and MHC functional peptide sites and their homology with HIV-1 gp120 oligopeptides: Role in AIDS pathogenesis. Proc Natl Acad Sci USA 90: 7573-7577
37. Zhou LJ, Tedder T (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154: 3821-3835
38. - dendritic cells. Proc Natl Acad Sci USA 93: 2588-2592
39. Zitvogel L, Mayordomo JI, Tjandrawan T, et al. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 183: 87-97